Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Merck
AstraZeneca
Harvard Business School
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Miglitol - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for miglitol and what is the scope of patent protection?

Miglitol is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn and Orient Pharma Co Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for miglitol. Three suppliers are listed for this compound.

Recent Clinical Trials for miglitol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Institutes of Health Research (CIHR)N/A
Drug Safety and Effectiveness Network, CanadaN/A
Canadian Network for Observational Drug Effect Studies, CNODESN/A

See all miglitol clinical trials

Pharmacology for miglitol
Synonyms for miglitol
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(2-hydroxymethyl)-3,4,5-piperidinetriol
(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol
(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
(2R,3R,4R,5S)-1-ethoxy-2-(hydroxymethyl)piperidine-3,4,5-triol
(2R,3R,4R)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-piperidine-3,4-diol
0V5436JAQW
1,5-Dideoxy-1,5-((2-hydroxyethyl)imino)-D-glucitol
1,5-dideoxy-1,5-[(2-hydroxyethyl)imino]-D-glucitol
3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-
432M032
72432-03-2
A837526
AB0014109
AB00639982_08
AB00639982-06
AB2000682
AC1L9AYD
ACN-040712
AK468667
AKOS015969689
AOB5559
Bay 1099
Bay m 1099
Bay m1009
Bay-m-1099
baym1099
BDBM50242271
BIDD:GT0732
BRD-K44779798-001-06-5
C07708
C8H17NO5
CAS-72432-03-2
CCG-100920
CHEBI:6935
CHEMBL1561
cid_441314
CPD000466381
CS-2596
CTK8G1117
D00625
DB00491
Diastabol
DSSTox_CID_3323
DSSTox_GSID_23323
DSSTox_RID_76977
DTXSID0023323
EINECS 276-661-6
FT-0628946
Glyset
Glyset (TN)
GTPL4842
HMS2051D05
HMS3713J07
HSDB 8022
HY-B0481
K230
KS-1242
M2302
MCULE-2158237443
Miglitol (Glyset)
Miglitol (JP17/USAN/INN)
Miglitol [USAN:INN:BAN]
Miglitolum
Miglitolum [Latin]
MLS000759514
MLS001424128
MLS006011963
MolPort-006-069-197
N-(2-Hydroxyethyl)-1-deoxynojirimycin
N-(b-Hydroxyethyl)-1-deoxynojirimycin
N-hydroxylethyl-1-deoxynojirimycin
NC00170
NCGC00095127-01
NCGC00270540-02
NE45506
Plumarol
PubChem21444
PubChem6069
RL04761
S2589
SAM001246745
SC-02811
SCHEMBL22593
Seibule
SK-983
SMR000466381
SR-01000759413
SR-01000759413-4
SYN3027
Tox21_111436
Tox21_111436_1
UNII-0V5436JAQW
W-104490
Z1541638520
ZINC4097426

US Patents and Regulatory Information for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-002 Feb 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
Orient Pharma Co Ltd MIGLITOL miglitol TABLET;ORAL 203965-003 Feb 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for miglitol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-001 Dec 18, 1996   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-003 Dec 18, 1996   Start Trial   Start Trial
Pharmacia And Upjohn GLYSET miglitol TABLET;ORAL 020682-002 Dec 18, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
McKesson
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.